Overview
Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis
Status:
Recruiting
Recruiting
Trial end date:
2021-12-31
2021-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to investigate the safety and clinical efficacy of HIP2101 in patients with acute or chronic gastritis.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Hanmi Pharmaceutical Company Limited
Criteria
Inclusion Criteria:- 19≤ age ≤ 75
- Have been diagnosed as acute or chronic gastritis with at least 1 erosion by endoscopy
within 7 days before enrollment.
- Patients understood the consents and purpose of this trial and signed consent form
Exclusion Criteria:
- Patients who cannot perform endoscopy
- Active gastric or duodenal ulcer
- Reflux esophagitis, barrett's esophagus, gastric or esophageal varix
- Zollinger-Ellison syndrome, pyloric obstruction, and esophageal stricture,
Inflammatory Bowel Diease, acute pancreatitis
- History of gastrointestinal surgery
- History of malignancy tumor, especially in the upper gastrointestinal tract
- Severe liver disorder(at screening day, AST or ALT level exceeds 3 times more than
normal upper range)
- Severe renal disorder(at screening day, MDRD eGFP ≤ 30 mL/min/1.73m2) or chronic renal
disease
- Bleeding disorder
- Patients who have taken drugs containing following list within 2 weeks before
endoscopy : H2-receptor antagonists, Proton pump inhibitors, P-CABs, gastrin
inhibitors, antacids, gastric mucosal protectants, anticholinergics
- Patients who have taken anticoagulants within a week before endoscopy
- Patients who have taken drugs containing following list after endoscopy : GI tract
regulators, salicylates, steroids, , NSAIDs, bisphosphonates, selective serotonin
reuptake inhibitors, iron supplements, oriental herbal medicines
- History of allergic reaction to the medications used in this study
- Use of other investigational drugs within 30 days prior to the study
- History of alcohol or drug abuse
- Positive to pregnancy test, nursing mother, intention on pregnancy
- Considered by investigator as not appropriate to participate in the clinical study
with other reason